News | February 18, 2022
Health Canada authorizes Novavax Covid-19 vaccine
Nuvaxovid is the first protein-based Covid-19 vaccine authorized for use in Canada
Nuvaxovid is the first protein-based Covid-19 vaccine authorized for use in Canada
The awards will be conferred to the winners at the annual summit of OPPI, scheduled on March 23-24
The award was given as a result of NASSCOM's meticulous screening process, in which over 700 start-ups were shortlisted as the most promising companies of the year
Yoga helps to build a strong immune system and daily breathing regime of 10-minute helps in the long run
Krivida Novus can detect the Omicron variant and its sub-lineages in 45 minutes
TATA MD’s OmiSure is the only test approved by the ICMR for RT-PCR detection of the Omicron variant
The test kit is compatible with all standard Real-Time PCR machines with a test run time of 85 minutes. The result turnaround time, including sample collection and RNA extraction, is 130 minutes
The first pilot study from India analyzing Covaxin-Covishield mixed doses
It plans to deliver over 300 million doses to the Indian government
The Indian Council of Medical Research (ICMR), intends to enter into non-exclusive agreements with companies
Subscribe To Our Newsletter & Stay Updated
